Profile data is unavailable for this security.
About the company
Klaria Pharma Holding AB (publ) is a Sweden-based holding company engaged in the biotechnology and medical research industry. Through its group subsidiaries, the Company is active in developing and commercializing therapeutic drugs and treatment methods in the fields of migraine and pain related to cancer based on a patented drug delivery platform in the form of an alginate-based polymer film, which facilitates rapid and reliable transmucosal absorption via a muco-adhesive film. The Company operates Klaria Pharma AB as a wholly owned subsidiary.
- Revenue in SEK (TTM)7.15m
- Net income in SEK-34.17m
- Incorporated2014
- Employees5.00
- LocationKlaria Pharma Holding AB (publ)Virdings Alle 2UPPSALA 754 50SwedenSWE
- Phone+46 84464299
- Websitehttps://www.klaria.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Peptonic Medical AB | 37.12m | -42.59m | 18.73m | 38.00 | -- | 0.2486 | -- | 0.5045 | -0.0362 | -0.0362 | 0.0326 | 0.0491 | 0.3857 | 1.32 | -- | 976,789.50 | -44.25 | -46.02 | -67.60 | -60.85 | 43.90 | 54.26 | -114.74 | -139.38 | 0.7771 | -29.32 | 0.0912 | -- | -14.93 | 149.65 | -15.55 | -- | 14.43 | -- |
| Cyxone AB | 0.00 | -22.99m | 20.56m | 4.00 | -- | 0.5276 | -- | -- | -0.1902 | -0.1902 | 0.00 | 0.1804 | 0.00 | -- | -- | -- | -47.81 | -66.19 | -53.03 | -72.35 | -- | -- | -- | -- | -- | -- | 0.0216 | -- | -- | -- | 45.87 | -- | -12.69 | -- |
| Asarina Pharma AB (publ) | 0.00 | -12.91m | 21.51m | -- | -- | 13.76 | -- | -- | -0.5704 | -0.5704 | 0.00 | 0.069 | 0.00 | -- | -- | -- | -113.04 | -61.28 | -150.47 | -71.81 | -- | -- | -- | -- | -- | -- | 0.3902 | -- | -- | -- | 2.79 | -- | -- | -- |
| Circio Holding ASA | 9.94m | -446.44m | 22.89m | 21.00 | -- | -- | -- | 2.30 | -71.33 | -71.33 | 1.58 | -10.64 | 0.0348 | -- | 0.8386 | 476,285.70 | -156.48 | -38.06 | -190.64 | -41.58 | -- | -- | -4,491.70 | -7,234.49 | -- | -94.77 | 3.71 | -- | -- | 206.46 | -341.86 | -- | 145.16 | -- |
| Gabather AB | 0.00 | -9.44m | 28.59m | -- | -- | 47.76 | -- | -- | -0.652 | -0.652 | 0.00 | 0.0331 | 0.00 | -- | -- | -- | -133.71 | -56.57 | -480.99 | -67.36 | -- | -- | -- | -17,298,800.00 | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- |
| Klaria Pharma Holding AB (publ) | 7.15m | -34.17m | 30.78m | 5.00 | -- | 0.7483 | -- | 4.31 | -0.3347 | -0.3498 | 0.0709 | 0.3862 | 0.0739 | -- | 0.5426 | 1,429,400.00 | -35.34 | -37.27 | -58.14 | -51.56 | -- | -- | -478.10 | -2,077.34 | -- | -7.65 | -- | -- | -100.00 | -- | 71.17 | -- | -- | -- |
| Fluicell AB | 3.34m | -26.55m | 33.01m | 17.00 | -- | 27.68 | -- | 9.89 | -0.2286 | -0.2286 | 0.0296 | 0.0036 | 0.1624 | 0.6813 | 3.84 | 196,352.90 | -129.20 | -87.55 | -222.48 | -126.02 | 52.07 | 72.97 | -795.51 | -650.23 | 0.5001 | -- | -- | -- | 2.68 | 22.18 | -22.90 | -- | -- | -- |
| Modus Therapeutics Holding AB | 0.00 | -17.90m | 37.02m | 2.00 | -- | 2.09 | -- | -- | -1.04 | -1.04 | 0.00 | 0.492 | 0.00 | -- | -- | 0.00 | -114.31 | -141.06 | -237.09 | -278.44 | -- | -- | -- | -- | -- | -10.96 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
| Elicera Therapeutics AB | 11.23m | -16.40m | 38.08m | 2.00 | -- | 1.31 | -- | 3.39 | -0.8289 | -0.8289 | 0.5677 | 0.8291 | 0.2936 | -- | 8.13 | 5,615,030.00 | -42.88 | -40.06 | -66.66 | -49.74 | -- | -- | -146.02 | -415.41 | -- | -- | 0.00 | -- | 777.23 | -- | 15.64 | -- | -- | -- |
| Lipigon Pharmaceuticals AB | 16.41m | -12.13m | 44.88m | -- | -- | 1.58 | -- | 2.74 | -0.3229 | -0.3229 | 0.2543 | 0.225 | 0.7388 | -- | 14.81 | -- | -54.60 | -314.67 | -75.05 | -426.49 | -- | -- | -73.91 | -488.14 | -- | -- | -- | -- | -- | 444.44 | 67.83 | -- | -- | -- |
Data as of Apr 25 2024. Currency figures normalised to Klaria Pharma Holding AB (publ)'s reporting currency: Swedish Krona SEK
